GRA

Grail

Stock
Stock
ISIN: US3847471014
Ticker: GRAL
US3847471014
GRAL

Price

Price

CHART BY

Frequently asked questions

What is Grail's market capitalization?

The market capitalization of Grail is $616.57M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Grail?

Grail's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$67.93. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Grail's stock?

Currently, 3 analysts cover Grail's stock, with a consensus target price of $16.00. Analyst ratings provide insights into the stock's expected performance.

What is Grail's revenue over the trailing twelve months?

Over the trailing twelve months, Grail reported a revenue of $117.67M.

What is the EBITDA for Grail?

Grail's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$648.33M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Grail?

Grail has a free cash flow of -$621.36M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the free float of Grail's shares?

The free float of Grail is 28.81M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$616.57M
EPS (TTM) 
-$67.93
Free Float 
28.81M
Revenue (TTM) 
$117.67M
EBITDA (TTM) 
-$648.33M
Free Cashflow (TTM) 
-$621.36M

Pricing

1D span
$16.74$18.98
52W span
$12.36$24.87

Analyst Ratings

The price target is $16.00 and the stock is covered by 3 analysts.

Buy

0

Hold

3

Sell

0

Information

GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
US3847471014
Primary Ticker
GRAL

Knockouts

Join the conversation